PL225B
/ Piramal Phytocare
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
September 02, 2014
Clinical Study of Oral IGF-1R Inhibitor in Subjects With Advanced Refractory Solid Tumors
(clinicaltrials.gov)
- P1; N=70; Suspended; Sponsor: Piramal Enterprises Limited; Active, not recruiting -> Suspended
Trial suspension • Biosimilar • Leukemia • Oncology
1 to 1
Of
1
Go to page
1